A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

被引:111
作者
Blasius, Melanie [1 ,2 ]
Forment, Josep V. [1 ,2 ]
Thakkar, Neha [1 ,2 ]
Wagner, Sebastian A. [3 ]
Choudhary, Chunaram [3 ]
Jackson, Stephen P. [1 ,2 ]
机构
[1] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England
[2] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England
[3] Univ Copenhagen, Fac Hlth Sci, NNF Ctr Prot Res, DK-2200 Copenhagen, Denmark
来源
GENOME BIOLOGY | 2011年 / 12卷 / 08期
基金
英国惠康基金;
关键词
DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; PHOSPHORYLATION DYNAMICS; ATR; INHIBITOR; PATHWAYS; PEPTIDE; BINDING; SITE; PURIFICATION;
D O I
10.1186/gb-2011-12-8-r78
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The cell-cycle checkpoint kinase Chk1 is essential in mammalian cells due to its roles in controlling processes such as DNA replication, mitosis and DNA-damage responses. Despite its paramount importance, how Chk1 controls these functions remains unclear, mainly because very few Chk1 substrates have hitherto been identified. Results: Here, we combine a chemical genetics approach with high-resolution mass spectrometry to identify novel Chk1 substrates and their phosphorylation sites. The list of targets produced reveals the potential impact of Chk1 function not only on processes where Chk1 was already known to be involved, but also on other key cellular events such as transcription, RNA splicing and cell fate determination. In addition, we validate and explore the phosphorylation of transcriptional co-repressor KAP1 Ser473 as a novel DNA-damage-induced Chk1 site. Conclusions: By providing a substantial set of potential Chk1 substrates, we present opportunities for studying unanticipated functions for Chk1 in controlling a wide range of cellular processes. We also refine the Chk1 consensus sequence, facilitating the future prediction of Chk1 target sites. In addition, our identification of KAP1 Ser473 phosphorylation as a robust readout for Chk1 activity could be used to explore the in vivo effects of Chk1 inhibitors that are being developed for clinical evaluation.
引用
收藏
页数:14
相关论文
共 61 条
[1]  
[Anonymous], PEPTIDEATLAS REP
[2]  
[Anonymous], Chimera
[3]   CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin? [J].
Antoni, Laurent ;
Sodha, Nayanta ;
Collins, Ian ;
Garrett, Michelle D. .
NATURE REVIEWS CANCER, 2007, 7 (12) :925-936
[4]   Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase [J].
Beck, Halfdan ;
Nahse, Viola ;
Larsen, Marie Sofie Yoo ;
Groth, Petra ;
Clancy, Trevor ;
Lees, Michael ;
Jorgensen, Mette ;
Helleday, Thomas ;
Syljuasen, Randi G. ;
Sorensen, Claus Storgaard .
JOURNAL OF CELL BIOLOGY, 2010, 188 (05) :629-638
[5]   Site-specific Phosphorylation Dynamics of the Nuclear Proteome during the DNA Damage Response [J].
Bennetzen, Martin V. ;
Larsen, Dorthe Helena ;
Bunkenborg, Jakob ;
Bartek, Jiri ;
Lukas, Jiri ;
Andersen, Jens S. .
MOLECULAR & CELLULAR PROTEOMICS, 2010, 9 (06) :1314-1323
[6]   ATM-Dependent and -Independent Dynamics of the Nuclear Phosphoproteome After DNA Damage [J].
Bensimon, Ariel ;
Schmidt, Alexander ;
Ziv, Yael ;
Elkon, Ran ;
Wang, Shih-Ya ;
Chen, David J. ;
Aebersold, Ruedi ;
Shiloh, Yosef .
SCIENCE SIGNALING, 2010, 3 (151)
[7]   A chemical switch for inhibitor-sensitive alleles of any protein kinase [J].
Bishop, AC ;
Ubersax, JA ;
Petsch, DT ;
Matheos, DP ;
Gray, NS ;
Blethrow, J ;
Shimizu, E ;
Tsien, JZ ;
Schultz, PG ;
Rose, MD ;
Wood, JL ;
Morgan, DO ;
Shokat, KM .
NATURE, 2000, 407 (6802) :395-401
[8]   Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates [J].
Blethrow, Justin D. ;
Glavy, Joseph S. ;
Morgan, David O. ;
Shokat, Kevan M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1442-1447
[9]  
Brown EJ, 2000, GENE DEV, V14, P397
[10]   Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance [J].
Brown, EJ ;
Baltimore, D .
GENES & DEVELOPMENT, 2003, 17 (05) :615-628